1. Ланг Г.Ф. О гипертонии. 1922.
2. Мясников А.Л., Гротель Д.Л. О содержании в крови холестерина и мочевой кислоты в связи с конституцией и болезнями обмена. 1926.
3. Vague J. Press Med 1947; 55: 339–40.
4. Reaven GM. Banting lecture 1988. Role of insulin resistance in human desease. Diabetеs 1988; 37: 1595–607.
5. Kaplan NM. The deadly quartet. Upper body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149: 1514–20.
6. World Health Organisation. Defintion, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation, Part 1: diagnosis and classification of diabetes mellitus, 1999.
7. Einhorn D, Reaven GM, Cobin RH et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003; 9 (3): 237–52.
8. Zimmet P, Alberti KG, Kaufman F et al. The metabolic syndrome in children and adolescents – an IDF consensus report. Pediatric Diabetes 2007; 8: 299–306.
9. Troiano RP, Flegal KM. Overweight prevalence among youth in the United States: why so many different numbers? Int J Obes Relat Metab Disord 1999; 23 (Suppl. 2): 22–7.
10. Ожирение. Руководство для врачей. Под ред. И.И.Дедова, Г.А.Мельниченко. М.: Медицинское информационное агентство, 2006.
11. Parsons TJ, Power C, Logan S, Summerbell CD. Childhood predictors of adult obesity: a systematic review. Int J Obes 1999; 23 (Suppl. 8): 1–107.
12. Bennett F, Watson-Brown C, Thame M et al. Shortness at birth is associated with insulin resistance in pre-pubertal Jamaican children. Eur J Clin Nutr 2002; 56: 506–11.
13. Hattersley AТ, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birth weight with diabetes and vascular disease. Lancet 1999; 353: 289.
14. Terauchi Y, Kubota N, Tamemoto H. Insulin effect during embryogenesis determines fetal growth: a possible molecular link between birth weight and susceptibility to type 2 diabetes. Diabetes 2000; 49 (1): 82–6.
15. Fowden AL. The role of insulin in prenatal growth. J Dev Physiol 1989; 12: 173–82.
16. Barker DJP, Hales CN, Fall CHD et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62–7.
17. Hoegsberg B, Gruppuso PA, Coustan DR. Hyperinsulinemia in macrosomic infants of non-diabetic mothers. Diabetes Care 1993; 16: 32–6.
18. Merzouk H, Meghelli-Bouchenak M, Loukidi B et al. Impaired serum lipids and lipoproteins in fetal macrosomia related to maternal obesity. Biol Neonate 2000; 77: 17–24.
19. Uauy R, Kain J. The epidemiologic transition: the need to incorporate obesity prevention into nutrition programmes. Public Health Nutr 2002; 5: 223–9.
20. Travers SH, Labarta JI, Gargosky SE et al. Insulin-like growth factor binding protein-I levels are strongly associated with insulin sensitivity and obesity in early pubertal children. J Clin Endocrinol Metab 1998; 83: 1935–9.
21. Косовский М.И. ИР при некоторых патологических и физиологических состояниях и пути ее устранения. Автореф. дис. … канд. биол. наук. Киев, 1990.
22. Frontini MG, Srinivasan SR, Berenson GS. Longitudinal changes in risk variables underlying metabolic Syndrome X from childhood to young adulthood in female subjects with a history of early menarche: the Bogalusa Heart Study. Int J Obes Relat Metab Disord 2003; 27 (11): 1398–404.
23. Davison KK, Birch LL. Obesigenic families: parents’ physical activity and dietary intake patterns predict girls’ risk of overweight. Int J Obes 2002; 26: 1186–93.
24. Cañete R, Gil-Campos M, Aguilera CM, Gil A. Development of insulin resistance and its relation to diet in the obese child. Eur J Nutr 2007; 46: 181–7.
25. Чазова И.Е., Мычка В.Б. Метаболический синдром. М.: Медиа Медика, 2008.
26. Insulin Resistance. Ed. by D.E.Moller. Chichester: John Wiley&Sons, 1993.
27. Малявская С.И., Дворяшина И.В., Терновская В.А. Метаболический инсулинрезистентный синдром: диагностика, клиническое значение, педиатрические аспекты. Монография. Архангельск: Изд-во Северного государственного медицинского университета, 2004.
28. Brown MS, Goldstein JL. In: S.I.Taylor, D.E.Moller. Insulin Resistence, 1993.
29. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000; 106: 171–6.
30. Morino K, Petersen KF, Dufour S et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 2005; 115: 3587–93.
31. Goran MI, Gower BA, Treuth M, Nagy TR. Prediction of intra-abdominal and subcutaneous abdominal adipose tissue in healthy pre-pubertal children. Int J Obes 1998; 22: 549–58.
32. James WPT, Jackson-Leach R, Mhurchu CN et al. Overweight and obesity (high body mass index). Comparative quantification of health risks. Geneva: World Health Organization, 2004.
33. Мазурин А.В., Воронцов И.М. Пропедевтика детских болезней. М., 1986.
34. Bellizzi MC, Dietz WH. Workshop on childhood obesity: summary of the discussion. Am J Clin Nutr (Suppl.) 1999; 70: 173–5.
35. Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: public health crisis, common sense cure. Lancet 2002; 360: 473–82.
36. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240–3.
37. Диагностика и лечение метаболического синдрома. Рекомендации ВНОК. Кардиоваскулярная терапия и профилактика (Прил. 2). 2007; 2.
38. International Diabetes Federation consensus worldwide definition of the metabolic syndrome. 14 April, 2005.
39. Cruz ML, Bergman RN, Goran MI. Unique effect of visceral fat on insulin sensitivity in obese Hispanic children with a family history of type 2 diabetes. Diabetes Care 2002; 25: 1631–6.
40. Weiss R, Dufour S, Taksali SE et al. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 2003; 362: 951–7.
41. Albu JB, Curi M, Shur M et al. Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity. Am J Physiol 1999; 277 (3 Pt 1): 551–60.
42. Caprio S, Hyman LD, Limb C et al. Central adiposity and its metabolic correlates in obese adolescent girls. Am J Physiol 1995; 269 (1 Pt 1): 118–26.
43. Saland JM. Update on the metabolic syndrome in children. Curr Opin Pediatr 2007; 19: 183–91.
44. Болотова Н.В., Лазебникова С.В., Аверьянов А.П. Особенности формирования метаболического синдрома у детей и подростков. Педиатрия. 2007; 3: 35–9.
45. Сорвачева Т.Н., Петеркова В.А., Титова Л.Н. и др. Ожирение у подростков. Лечащий врач. 2006; 4: 50–4.
46. Thamer C, Machann J, Bachmann O et al. Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 2003; 88: 1785–91.
47. Kelley DE, McKolanis TM, Hegazi RA et al. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 2003; 285: 906–16.
48. Weiss R, Taksali SE, Dufour S et al. The «obese insulin-sensitive» adolescent: importance of adiponectin and lipid partitioning. J Clin Endocrinol Metab 2005; 90: 3731–7.
49. Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению. РМЖ. 2001; 9 (2): 56–60.
50. Steinberger J. Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 2003; 107 (10): 1448–53.
51. Weiss R, Dziura J, Burgert TS et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362–74.
52. Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab 2004; 89: 2526–39.
53. Kurtoğlu S, Hatipoğlu N, Mazıcıoğlu M et al. Insulin Resistance in Obese Children and Adolescents: HOMA−IR Cut−Off Levels in the Prepubertal and Pubertal Periods. J Clin Res Pediatr Endocrinol 2010; 2 (3): 100–6.

И.Н.Захарова1, Л.А.Звенигородская2, С.И.Малявская3, Т.М.Творогова1, С.В.Яблочкова1

1 ГБОУ ДПО Российская медицинская академия последипломного образования Минздрава РФ, Москва
2 ГБУЗ Центральный научно-исследовательский институт гастроэнтерологии Департамента здравоохранения г. Москвы
3 ГБОУ ВПО Северный государственный медицинский университет Минздрава РФ, Архангельск